The C. diff study was funded in part by BioNTech, which made some of the mRNA COVID-19 vaccines with Pfizer.In addition, Penn ...

Matthew Munneke, left, and Eric Skaar, PhD, MPH, use anaerobic chambers to study bacteria like C. diff that die in the presence of oxygen. The pathogen C. diff — the most common cause of health ...

The ongoing trial is testing the therapy – RBX2660 – as a treatment for Clostridioides difficile infection or C. diff, a bacterium that causes diarrhoea and inflammation in the colon and is a ...

Clostridioides difficile (previously known as Clostridium difficile) is a highly contagious organism that primarily impacts ...

Clostridium difficile infection (CDI ... There are several microbiological tests available, but glutamate dehydrogenase antigen test can be selected as the first screening step in a diagnostic ...

The pathogen C. diff - the most common cause of health care-associated infectious diarrhea - can use a compound that kills the human gut's resident microbes to survive and grow, giving it a ...

Once C-diff is in the ascendancy it can be very hard ... only 6% of potential donors make it through the rigorous testing programme. Although this treatment is relatively new it has had staggering ...

The pathogen C. diff -- the most common cause of health care-associated infectious diarrhea -- can use a compound that kills the human gut's resident microbes to survive and grow, giving it a ...

Get Instant Summarized Text (Gist) C. diff, a major cause of healthcare-associated diarrhea, can utilize the toxic compound 4-thiouracil as a nutrient, giving it a competitive edge in the gut ...